How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code LAO: Enzyme Immunoassay, Methotrexate. View classification details, related manufacturers, 510(k) clearances, and recall records.
10 clearance records and 2 recall records in the covered releases, across 8 source company names and 1 product codes. Dated history runs from Oct 10, 1978 to Feb 20, 2024.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| LAO · Enzyme Immunoassay, Methotrexate | 10 | 2 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| ONLINE TDM MethotrexateK233454 · LAO | Roche Diagnostics Operations | 510(k) | Feb 20, 2024FDA decision date |
| ARK Methotrexate II AssayK232017 · LAO | Ark Diagnostics, Inc. | 510(k) | Dec 20, 2023FDA decision date |
| ARK Methotrexate AssayK163359 · LAO | Ark Diagnostics, Inc. | 510(k) | Aug 18, 2017FDA decision date |
| Syva Emit Methotrexate Assay, is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of methotrexate in human serum or…Z-1618-2016 · LAO | Siemens Healthcare Diagnostics, Inc. | Recall | May 6, 2016FDA classification date |
| ARK METHOTREXATE ASSAY, ARK METHOTREXATE CALIBRATOR, ARK METHOTREXATE CONTROL, ARK METHOTREXATE CONTROL (CALIBRATION RANK111904 · LAO | Ark Diagnostics, Inc. | 510(k) | Oct 18, 2011FDA decision date |
| TDx/TDxFLx Methotrexate II Reagent-List Number 07A12-60 - a reagent system for In Vitro diagnostic use. This reagent system is composed of one bo…Z-1056-2007 · LAO | Abbott Diagnostic International, Ltd. | Recall | Jul 20, 2007FDA classification date |
| TDX(R)/TDX(R)FLX(R)MEHTOTREXATE IIK932615 · LAO | Abbott Laboratories | 510(k) | Jul 14, 1993FDA decision date |
| ACA DU PONT METHOTREXATE (MTHO) METHODK884744 · LAO | E.I. Dupont DE Nemours & Co., Inc. | 510(k) | Jan 30, 1989FDA decision date |
| EMIT & METHOFREXATE ASSAYK833634 · LAO | Syva Co. | 510(k) | Dec 22, 1983FDA decision date |
| TDX METHOTREXATEK830398 · LAO | Abbott Laboratories | 510(k) | Mar 10, 1983FDA decision date |
| EMIT-AND METHOTREXATE ASSAYK811459 · LAO | Syva Co. | 510(k) | Jun 9, 1981FDA decision date |
| EMIT METHATREXATE ASSAYK781381 · LAO | Dade Behring, Inc. | 510(k) | Oct 10, 1978FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.